AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...
Some young shoppers will continue to buy from the fast fashion giant despite concerns over how workers are treated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback